STOCK TITAN

Interparfums forecasts about $5 in FY2027 diluted EPS

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Interparfums, Inc. (IPAR) announced initial fiscal 2027 guidance, projecting net sales of approximately $1.58 billion, up 6%, and diluted EPS of approximately $5.00, up 3%. The 2026 estimates are $1.49 billion in net sales and $4.85 in diluted EPS; the EPS estimate includes a one-time $17.9 million gain, or $0.35 per diluted share, related to IEEPA tariff refunds. The 2027 guidance assumes no comparable benefit; excluding the 2026 benefit, diluted EPS is estimated to increase approximately 11%.

Sales growth is expected to reflect leading brands, new-brand debuts and product launches, partly offset by softer performance from smaller brands, licenses expiring at the end of 2026 and 2027, and challenges in the Middle East and Eastern Europe. The outlook assumes an approximately 1% unfavorable foreign-exchange impact on sales. EPS growth is expected to be partly offset by elevated brand investment and marketing spending for 2027 launches and 2028 innovation initiatives.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 0 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Moderate point. Forward-looking: it has not happened yet and may not happen.2027 net sales guidance increases 6% to approximately $1.58 billion.

Negative

  • None.
Item 7.01 Regulation FD Disclosure Disclosure
Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
2027E net sales Approximately $1.58 billion; +6% Fiscal 2027 guidance compared with 2026 estimate
2026E net sales $1.49 billion 2026 estimate in the guidance comparison
2027E diluted EPS Approximately $5.00; +3% Fiscal 2027 guidance compared with 2026 estimate
2026E diluted EPS $4.85 Estimate includes a benefit related to IEEPA tariff refunds
One-time gain related to IEEPA tariff refunds $17.9 million Included in estimated 2026 results
Tariff-refund benefit $0.35 per diluted share Included in estimated 2026 diluted EPS
2027E diluted EPS increase excluding the 2026 benefit Approximately 11% Comparison excludes the 2026 tariff-refund benefit
Foreign-exchange impact on net sales Approximately 1% unfavorable 2027 outlook based on current rates
diluted EPS financial
"Diluted EPS is expected to increase 3%"
Diluted earnings per share (EPS) shows how much profit a company makes for each share of stock, assuming all possible shares from stock options or convertible securities are used. It provides a more conservative estimate than basic EPS, accounting for potential share increases that could dilute ownership. Investors use diluted EPS to get a clearer picture of a company's true profitability on a per-share basis.
IEEPA tariff refunds regulatory
"related to IEEPA tariff refunds"
Refunds under the International Emergency Economic Powers Act (IEEPA) are repayments of import duties, fees, or penalties that were charged because of trade restrictions or sanctions put in place under emergency authority and later reversed, modified, or found inapplicable. For investors, these refunds can change a company’s past cash outflows and future cost structure—similar to getting a billed charge returned after a rule change—affecting reported earnings or cash available for other uses.
foreign exchange impact financial
"approximately 1% unfavorable foreign exchange impact on net sales"
The foreign exchange impact is the change in a company’s reported financial results, cash flows or asset values that comes from movements in currency exchange rates. Like converting prices from one currency to another, shifting rates can make sales, costs and overseas holdings look bigger or smaller when translated into the company’s reporting currency, affecting reported profit, balance sheets and comparisons across periods.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are Interparfums (IPAR)’s 2027 sales and diluted EPS forecasts?

Net sales are projected at approximately $1.58 billion, up 6%, and diluted EPS at approximately $5.00, up 3%. The comparison uses 2026 estimates of $1.49 billion in sales and $4.85 in diluted EPS.

How does the 2026 tariff refund affect Interparfums’ 2027 EPS comparison?

The 2026 diluted EPS estimate includes a $0.35 per diluted share benefit from a one-time $17.9 million gain related to IEEPA tariff refunds; 2027 guidance assumes no comparable benefit. Excluding that benefit, 2027 diluted EPS is estimated to increase approximately 11%.

What foreign-exchange impact does Interparfums expect on 2027 sales?

An approximately 1% unfavorable impact on net sales is assumed, based on current rates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
NY false 000082266300008226632026-11-182026-11-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

 Date of Report (Date of Earliest Event Reported): November 18, 2026 

 
Interparfums, Inc.
(Exact name of Registrant as specified in its charter)

 

Delaware

 

0-16469

 

13-3275609

(State or other jurisdiction of
incorporation or organization)

 

Commission
File Number

 

(I.R.S. Employer
Identification No.)

 

551 Fifth Avenue, New York, NY 10176
(Address of Principal Executive Offices)

 

212.983.2640
(Registrant’s Telephone number, including area code)

 

   (Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions (see General Instruction A.2 below):

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting Material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

 

Trading Symbol(s)

 

Name of each exchange
on which registered

 

 

 

 

 

 Common Stock, $.001 par value per share

 

IPAR

 

The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


Item 7.01 Regulation FD Disclosure

 

Our press release dated November 18, 2026 relating to initial 2027 guidance and factors contributing to guidance, a copy of which is annexed hereto as Exhibit 99.1, is incorporated by reference herein, and is filed pursuant to this Item 7.01 and Regulation FD.

 

Item 9.01 Financial Statements and Exhibits.

 

99.1

Our press release dated November 18, 2026

 


SIGNATURES

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused and authorized this report to be signed on its behalf by the undersigned.

 

Dated: November 18, 2026

 

 

Interparfums, Inc.

 

 

 

By:

/s/ Michel Atwood

 

 

Michel Atwood,

 

 

Chief Financial Officer

 


 

Exhibit 99.1

Graphics

FOR IMMEDIATE RELEASE

 

INTERPARFUMS, INC. ANNOUNCES FULL YEAR 2027 GUIDANCE

 

New York, New York, November 18, 2026, Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced initial guidance for its fiscal year ending December 31, 2027. In evaluating the annual comparison, management noted that full year 2026 estimated results will include the effect of a one-time gain of $17.9 million, or $0.35 per diluted share, related to IEEPA tariff refunds. The Company’s 2027 guidance does not assume a comparable benefit. 

 

Guidance

2027E

2026E

% Change

Net Sales

$1.58 billion

$1.49 billion

+6%

Diluted EPS

$5.00

$4.85*

+3%

*Diluted EPS for 2026 includes an estimated $0.35 per diluted share benefit associated with IEEPA tariff refunds.

 

Management Commentary

Jean Madar, Chairman & Chief Executive Officer of Interparfums stated, “Throughout 2026, we have focused on launching extensions for key fragrance lines across the portfolio, investing in brand marketing, supporting partner and customer demand, and enhancing our operational efficiency. With an eye toward the future, we entered into new licensing agreements, extended select fragrance partnerships, and invested in preparations for blockbuster launches in 2027 − positioning our portfolio to capitalize on evolving consumer demand and supporting long-term growth.”

Mr. Madar continued, “These initiatives have positioned us for a strong 2027. Consolidated net sales are expected to grow 6% to approximately $1.58 billion in 2027, driven by continued growth in our leading brands, blockbuster launches across our existing portfolio, and fragrance debuts from our newest brands. We expect these gains to be partially offset by softer performance from smaller brands, the phasing out of a few licenses expiring at the end of 2026 and 2027, and continuing challenges in the Middle East and Eastern Europe. Our outlook also assumes an approximately 1% unfavorable foreign exchange impact on net sales based upon current rates. 

“Diluted EPS is expected to increase 3% to approximately $5.00 in 2027, primarily driven by top line growth and enhanced operating efficiencies, partially offset by elevated brand investment and marketing spending to support blockbuster launches in 2027 and major innovation initiatives planned for 2028. Excluding the favorable impact of tariff refunds in 2026, diluted EPS for 2027 is estimated to increase by approximately 11%.”    

Mr. Madar concluded, “We enter 2027 with momentum and a clear focus on innovation, disciplined investment, and efficient execution to drive profitable growth while navigating a challenging economic backdrop.”

 

Extensive Line-Up of Blockbusters and Extensions

European Based Operations

For our European based operations, 2027 will benefit from a particularly rich launch plan encompassing initiatives for the portfolio's established brands and contributions from new brands Off-White, Annick Goutal and Longchamp:

            The first half will see the launch of three new franchises for Lacoste, Coach and Montblanc fragrances, which will strengthen the potential of these brands over the coming years;

            The second half will notably benefit from the launch of Longchamp fragrances, the first initiative since the license was signed in July 2025.

In addition to these major initiatives, several line extensions will support the business throughout the year.

1



United States Based Operations

For our U.S. operations, 2027 will bring an exciting lineup of blockbuster launches and innovative product extensions that will strengthen our established franchises, alongside new product introductions across several other brands. These include:

            New blockbusters, including a new women's fragrance for GUESS in early 2027, a new dual-gender duo for Ferragamo, the launch of Serpentine Man for Roberto Cavalli building on the success of Serpentine, and a new female line  for MCM.

            The debut of our first new PUMA fragrances under the exclusive license announced in September 2026, featuring a blockbuster duo for men and women.

In addition to these major launches, we will introduce new extensions and collections across the portfolio, supporting overall growth throughout the year.

About Interparfums, Inc.

Operating in the global fragrance business since 1982, Interparfums, Inc. produces and distributes a wide array of prestige fragrance and fragrance related products under license and other agreements with brand owners. The Company manages its business in two operating segments, European based operations, through its 74% owned subsidiary, Interparfums SA, and United States based operations, through wholly owned subsidiaries in the United States and Italy.

Our licensed portfolio of prestige brands includes Abercrombie & Fitch, Anna Sui, Boucheron, Coach, Donna Karan/DKNY, Emanuel Ungaro, Ferragamo, Graff, GUESS, Hollister, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Longchamp, MCM, Moncler, Montblanc, Oscar de la Renta, PUMA, Roberto Cavalli, and Van Cleef & Arpels, whose products are distributed in over 120 countries around the world through an extensive and diverse network of distributors. Interparfums, Inc. is also the registered owner of several trademarks including Annick Goutal, Lanvin, Off-White, Rochas, and Solférino.

Forward-Looking Statements

Statements in this release which are not historical in nature are forward-looking statements. Although we believe that our plans, intentions, and expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such plans, intentions, or expectations will be achieved. In some cases, you can identify forward-looking statements by forward-looking words such as “anticipate,” “believe”, “could”, “estimate”, “expect”, “intend”, “may”, “should”, “will”, and “would” or similar words. You should not rely on forward-looking statements, because actual events or results may differ materially from those indicated by these forward-looking statements as a result of a number of important factors. These factors include, but are not limited to, the risks and uncertainties discussed under the headings “Forward Looking Statements” and “Risk Factors” in Interparfums' annual report on Form 10-K for the fiscal year ended December 31, 2025, and the reports Interparfums files from time to time with the Securities and Exchange Commission. Interparfums does not intend to and undertakes no duty to update the information contained in this press release.

Contact Information

Interparfums, Inc.

or

The Equity Group Inc.

Michel Atwood

 

Devin Sullivan: (212) 836-9608 / devin.sullivan@theequitygroup.com

Chief Financial Officer

 

Conor Rodriguez: (212) 836-9628 / conor.rodriguez@theequitygroup.com

(212) 983-2640

 

www.theequitygroup.com

www.interparfumsinc.com

 

 

 

2


 

Filing Exhibits & Attachments

6 documents

Keep reading